| Mar 23 | Mar 22 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 25.86M | $ 61.25M | $ 27.46M | $ 5.53M |
| Gross Profit | $ -2.58M | $ 23.48M | $ 6.12M | $ -5.45M |
| Operating Income | $ -31.98M | $ -2.41M | $ -15.47M | $ -23.06M |
| EBITDA | $ -30.24M | $ 228.00K | $ -16.57M | $ -24.11M |
| Net Income | $ -32.09M | $ -2.82M | $ -17.81M | $ -25.14M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 12.90M | $ 28.86M | $ 14.37M | $ 9.30M |
| Total Assets | $ 30.87M | $ 60.42M | $ 47.45M | $ 17.73M |
| Total Debt | $ 12.11M | $ 12.67M | $ 12.23M | $ 2.54M |
| Net Debt | $ -788.00K | $ -16.19M | $ -2.14M | $ -6.76M |
| Total Liabilities | $ 22.01M | $ 22.94M | $ 23.76M | $ 6.53M |
| Stockholders' Equity | $ 8.86M | $ 37.48M | $ 23.69M | $ 11.20M |
| Cash Flow | ||||
| Free Cash Flow | $ -14.10M | $ 2.12M | $ -20.65M | $ -23.78M |
| Operating Cash Flow | $ -13.29M | $ 3.69M | $ -19.79M | $ -23.05M |
| Investing Cash Flow | $ -807.00K | $ -1.57M | $ -866.81K | $ -735.30K |
| Financing Cash Flow | $ -1.87M | $ 12.38M | $ 25.72M | $ 29.66M |
Biocept (DE:B00)
FRANKFURT:B00
